Results 161 to 170 of about 158,149 (351)

The interaction between atrial fibrillation and mitral regurgitation: Insights from the CABANA randomized clinical trial

open access: yesEuropean Journal of Heart Failure, EarlyView.
Effects of baseline mitral regurgitation in the CABANA trial: randomization to catheter ablation versus drug therapy in patients with atrial fibrillation. AF, atrial fibrillation; CCS, Canadian Cardiovascular Society; MR, mitral regurgitation; NYHA, New York Heart Association; OR, odds ratio.
Sebastiaan Dhont   +8 more
wiley   +1 more source

Long-term outcome after mitral valve repair: a risk factor analysis [PDF]

open access: yes, 2017
Objective: Mitral valve repair is the gold standard to restore mitral valve function and is now known to have good long-term outcome. In order to help perioperative decision making, we analyzed our collective to find independent risk factors affecting ...
Eisa, Karam   +5 more
core  

3-Year Outcomes of Transcatheter Mitral Valve Repair in Patients With Heart Failure.

open access: yesJournal of the American College of Cardiology, 2021
M. Mack   +17 more
semanticscholar   +1 more source

On-pump fibrillating heart mitral valve replacement with the SAPIEN™ XT transcatheter heart valve [PDF]

open access: yes, 2017
In some high-risk patients, standard mitral valve replacement can represent a challenging procedure, requiring a risky extensive decalcification of the annulus. In particular, high-risk redo patients and patients with a previously implanted transcatheter
Ferrari, Enrico   +3 more
core  

Aetiological phenotypes of atrial and ventricular secondary tricuspid regurgitation and their prognostic implications: insights from the CARE‐TR registry

open access: yesEuropean Journal of Heart Failure, EarlyView.
Aetiological phenotypes of secondary tricuspid regurgitation. AF, atrial fibrillation; HFpE, heart failure with preserved ejection fraction; CARE‐TR, Consecutive pAtients with seveRE Tricuspid Regurgitation evaluated in Heart Failure and Valve Clinics; HF, heart failure; HFmrEF, heart failure with mildly reduced ejection fraction; HFrEF, heart failure ...
Laura Lupi   +17 more
wiley   +1 more source

Management of tricuspid regurgitation in patients undergoing mitral valve replacement for rheumatic mitral valve diseases [PDF]

open access: yes, 2012
BACKGROUND: In mitral valve diseases associated with long standing pulmonary hypertension,Tricuspid annulus dilates and fails to shorten during systole leading to Tricuspid regurgitation.Tricuspid regurgitation contributes to both the morbidity and ...
Prasanna, R
core  

Percutaneous Mitral Valve Repair

open access: yesJournal of Interventional Cardiology, 2007
Nonsurgical treatment of clinically important mitral regurgitation (MR) has evolved tremendously over the past decade. Recent studies of percutaneous mitral valve repair procedures have shown that less invasive procedures are safe and can be effective in selected patients. MitraClip has been studied most extensively.
openaire   +3 more sources

Employment of artificial intelligence for an unbiased evaluation regarding the recovery of right ventricular function after mitral valve transcatheter edge‐to‐edge repair

open access: yesEuropean Journal of Heart Failure, EarlyView.
Impact of mitral transcatheter edge‐to‐edge repair (M‐TEER) on left and right heart function. IQR, interquartile range; LA, left atrial; RVEF, right ventricular ejection fraction; sPAP, systolic pulmonary artery pressure; TAPSE, tricuspid annular plane systolic excursion. Abstract Aims Long‐standing severe mitral regurgitation (MR) leads to left atrial
Vera Fortmeier   +21 more
wiley   +1 more source

Prognostic value of NT‐proBNP in patients with primary mitral regurgitation undergoing transcatheter edge‐to‐edge repair

open access: yesEuropean Journal of Heart Failure, EarlyView.
In the PRIME‐MR study, patients with higher N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP) tertiles more frequently reached death or heart failure hospitalization (HFH) within 3 years. Log‐transformed NT‐proBNP levels independently predicted the primary endpoint (adjusted hazard ratio 1.17, 95% confidence interval 1.07–1.28; p < 0.001).
Philipp von Stein   +70 more
wiley   +1 more source

Home - About - Disclaimer - Privacy